Diabetes affects the life quality of a number of people largely through the cardiovascular complications [1] . Vascular endothelial cells play a major role in maintaining vascular homeostasis [2] . Dysfunction of the vascular endothelium is a critical factor in the pathogenesis of diabetic micro-and macrovascular diseases [2, 3] . The fundamental mechanism contributing to vascular disease, nephropathy, retinopathy, and neuropathy has yet to translate into effective therapeutics [4] . Uncovering novel mechanism governing endothelium dysfunction, new concepts about biological pathways involved in diabetic tissue injury, and identification of new therapeutics are of significance [5] . Circulating endothelial progenitor cells (EPCs) in diabetes are reduced and dysfunctional [6] [7] [8] , suggesting EPC as a biomarker for diabetes and a prospective target for regenerative medicine [9] . Although significant strides have been made, the molecular mechanism of diabetic complications in vascular diseases and the effective treatment remain largely unknown. In this special issue, investigators have identified novel mechanism and therapeutics from their original research or review articles on the role of endothelial dysfunction in the etiology and pathogenesis of the micro-and macrovascular complications of diabetes, as well as therapeutic practice. Among the top gear, diabetes badly affects the function of retina and kidney. X. Cai and J. As reported in recent years, endothelial progenitor cells (EPCs) are reduced in circulation [8, 9] Taken together, the articles in this special issue could further help researchers to understand the complexity of the diabetic complications in cardiovascular system and provide some new ideas to fight against diabetic cardiovascular complications.
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